ConductScience.org, home

Paper728322

The features of hepatic enzyme induction with glutethimide in man.

Jackson L and 2 others. Br J Clin Pharmacol, 1978. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. The features of hepatic enzyme induction with glutethimide in man. Papers, record 728322. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/728322

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The features of hepatic enzyme induction with glutethimide in man.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.26
iCite
Revised in PubMed
2019-05-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jackson LL
2Homeida MM
3Roberts CJC J

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlutethimideMajor topic
LiverMajor topic
Antipyrine
Enzyme Induction
Glucaric Acid
Half-Life
Humans
Indocyanine Green
Kinetics
Male

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114153720[THE BIOCHEMICAL INTERPRETATION OF HYPNOTIC ADDICTION].Schweiz Med Wochenschr1964https://conductscience.org/library/papers/14153720PubMed
216748985Metabolism of d-glucuronolactone in mammalian systems. Identification of d-glucaric acid as a normal constituent of urine.Biochem J1963https://conductscience.org/library/papers/16748985PubMed
313689739The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.Clin Sci1961https://conductscience.org/library/papers/13689739PubMed
4332216Factors influencing antipyrine elimination.Br J Clin Pharmacol1977https://conductscience.org/library/papers/332216PubMed
5973986The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.Br J Clin Pharmacol1976https://conductscience.org/library/papers/973986PubMed
65285387Clinical implications of enzyme induction.Ann N Y Acad Sci1971https://conductscience.org/library/papers/5285387PubMed
74144245Osteomalacia after prolonged glutethimide administration.Br Med J1973https://conductscience.org/library/papers/4144245PubMed
85087064The stimulant effect of drugs on indocyanine green clearance by the liver.Gut1972https://conductscience.org/library/papers/5087064PubMed
94810112Enzyme induction and medical treatment.J R Coll Physicians Lond1974https://conductscience.org/library/papers/4810112PubMed
104383307Pharmacological implications of microsomal enzyme induction.Pharmacol Rev1967https://conductscience.org/library/papers/4383307PubMed
114100904Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man.Lancet1971https://conductscience.org/library/papers/4100904PubMed
124205524Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.J Clin Invest1974https://conductscience.org/library/papers/4205524PubMed
134856673Urinary D-glucaric acid assay by an improved enzymatic procedure.Clin Chim Acta1974https://conductscience.org/library/papers/4856673PubMed
144746322Hemodynamic drug interactions: the reduction of oxyphenbutazone clearance by dl-propranol in the dog.J Pharmacol Exp Ther1973https://conductscience.org/library/papers/4746322PubMed
151109248Clinical implications of warfarin interactions with five sedatives.Am J Cardiol1975https://conductscience.org/library/papers/1109248PubMed
165114497Changes in liver blood flow during enzyme induction.Biochem Pharmacol1971https://conductscience.org/library/papers/5114497PubMed
175568259Disposition of glutethimide in man.Clin Pharmacol Ther1971https://conductscience.org/library/papers/5568259PubMed
185763659The effects of phenobarbital, chloral betaine, and glutethimide administration on warfarin plasma levels and hypoprothrombinemic responese in man.Clin Pharmacol Ther1969https://conductscience.org/library/papers/5763659PubMed
195650142Studies on the mechanism of phenobarbital-enhanced sulfobromophthalein disappearance.J Pharmacol Exp Ther1968https://conductscience.org/library/papers/5650142PubMed
205996677Effect of phenobarbital and glutethimide on biological half-life of warfarin.Thromb Diath Haemorrh1966https://conductscience.org/library/papers/5996677PubMed

See all 21 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
6690067Aminoglutethimide and warfarin. A new important drug interaction.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6690067PubMed
6487491The effect of acetylator phenotype on the disposition of aminoglutethimide.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6487491PubMed
6128018Assessment of the drug metabolism capacity of the liver.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6128018PubMed
6115663Physiological and pharmacological variability in estimated hepatic blood flow in man.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6115663PubMed
6113907Clinical implications of enzyme induction and enzyme inhibition.Clin Pharmacokinet1981https://conductscience.org/library/papers/6113907PubMed
3978028Observations on the pharmacokinetics of low dose aminoglutethimide in patients with advanced breast cancer.Br J Cancer1985https://conductscience.org/library/papers/3978028PubMed
2868749D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy.Br J Clin Pharmacol1986https://conductscience.org/library/papers/2868749PubMed
533576The [14C]-aminopyrine breath test. A comparison of different forms of analysis.Br J Clin Pharmacol1979https://conductscience.org/library/papers/533576PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/728322

GET https://conductscience.org/api/papers/v1/728322/references?page=2